INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57,545 | -43.4% | 8,500 | -24.1% | 0.00% | – |
Q2 2023 | $101,696 | +98.4% | 11,200 | +41.1% | 0.00% | – |
Q1 2023 | $51,260 | -13.1% | 7,935 | -14.2% | 0.00% | – |
Q4 2022 | $59,000 | +55.3% | 9,250 | +52.9% | 0.00% | – |
Q3 2022 | $38,000 | -22.4% | 6,050 | +8.9% | 0.00% | – |
Q2 2022 | $49,000 | -82.4% | 5,557 | -83.2% | 0.00% | -100.0% |
Q1 2022 | $279,000 | -23.4% | 33,100 | -7.4% | 0.00% | 0.0% |
Q4 2021 | $364,000 | +53.6% | 35,738 | +193.7% | 0.00% | – |
Q3 2021 | $237,000 | -50.5% | 12,170 | -55.4% | 0.00% | -100.0% |
Q2 2021 | $479,000 | +409.6% | 27,262 | +241.5% | 0.00% | – |
Q1 2021 | $94,000 | -8.7% | 7,982 | +33.0% | 0.00% | – |
Q4 2020 | $103,000 | +66.1% | 6,000 | 0.0% | 0.00% | – |
Q3 2020 | $62,000 | +6100.0% | 6,000 | +2900.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 200 | -33.3% | 0.00% | – |
Q1 2020 | $1,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |